Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Plager

Showing results (41-50 of 341) with videos related to

Pageof 35
Sort By:
Melanoma Research|October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary resultsA C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer Drug Delivery|January 1, 1984
Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumorsL G Feun, S Wallace, W K Yung, et al.
Seminars in Diagnostic Pathology|August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factorA K Raymond, S P Chawla, C H Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcomaS Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Melanoma Research|June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanomaA C Buzaid, F Ali-Osman, N Akande, et al.
Melanoma Research|June 4, 1998
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapyC M Anderson, A C Buzaid, J Sussman, et al.
Melanoma Research|January 26, 1999
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastasesA C Buzaid, M Colome, A Bedikian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanomaO Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
Pageof 35

Showing results (41-50 of 341) with videos related to

Sort By:
Pageof 35
Melanoma Research|October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary resultsA C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer Drug Delivery|January 1, 1984
Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumorsL G Feun, S Wallace, W K Yung, et al.
Seminars in Diagnostic Pathology|August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factorA K Raymond, S P Chawla, C H Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcomaS Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Melanoma Research|June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanomaA C Buzaid, F Ali-Osman, N Akande, et al.
Melanoma Research|June 4, 1998
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapyC M Anderson, A C Buzaid, J Sussman, et al.
Melanoma Research|January 26, 1999
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastasesA C Buzaid, M Colome, A Bedikian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanomaO Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
Pageof 35